Best Practice for Clinical Monitoring
Applied Clinical Trials
Our book review for the latest industry guidebook for monitors.
Author Gerald Van Roey has over 10 years of experience as a clinical monitor. His book offers sharp insights for both the new and experienced monitor.
After the first chapter primer about clinical research, Van Roey delves into the more granular areas of the practice of clinical monitoring. For that, the best chapter is Chapter 2. It looks at the qualities that make a good monitor and the relationship with an investigator.
Clinical Monitoring
Chapter 7 offers the reader a good grasp of initiation visits and tips on how to approach the study personnel.
Chapter 8, titled Monitoring Visits, is a large part of the book and takes on a lot. There is discussion about the import and export of clinical supplies, IMP distribution, tracking, and return of used IMP, which is very interesting and something with which I didn't have a lot of knowledge, and found very helpful.
Sections on site management, recruitment issues, the right protocol, and site selection included good information, but maybe not so related to the function of monitoring. Subject recruitment is a very complex area of clinical trials. It requires many initiatives that all fire on the same cylinders to ensure rapid and inclusive enrollment. The chapter offers several good ideas such as the monitor playing a part in communicating protocol information to the site, pinpointing problem areas, and suggesting solutions. But the section seems geared to the pharmaceutical company, or the CROs function.
Overall, the book is well written, with a pleasing design. It offers excellent tips, drawing these out in colored boxes to help the reader.
The book is available from the publisher PharmImage, www.PharmImage.com, and costs €39.95, or approximately $56.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
